{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:35:48Z","timestamp":1790390148784,"version":"4.1.0"},"reference-count":45,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":3605,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To determine whether dietary compounds targeting NFE2-related factor 2 (Nrf2) activation can be used to attenuate renal damage and preserve renal function during the course of streptozotocin (STZ)-induced diabetic nephropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Diabetes was induced in Nrf2+\/+ and Nrf2\u2212\/\u2212 mice by STZ injection. Sulforaphane (SF) or cinnamic aldehyde (CA) was administered 2 weeks after STZ injection and metabolic indices and renal structure and function were assessed (18 weeks). Markers of diabetes including blood glucose, insulin, polydipsia, polyuria, and weight loss were measured. Pathological alterations and oxidative damage in glomeruli were also determined. Changes in protein expression of the Nrf2 pathway, as well as transforming growth factor-\u03b21 (TGF-\u03b21), fibronectin (FN), collagen IV, and p21\/WAF1Cip1 (p21) were analyzed. The molecular mechanisms of Nrf2-mediated protection were investigated in an in vitro model using human renal mesangial cells (HRMCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>SF or CA significantly attenuated common metabolic disorder symptoms associated with diabetes in Nrf2+\/+ but not in Nrf2\u2212\/\u2212 mice, indicating SF and CA function through specific activation of the Nrf2 pathway. Furthermore, SF or CA improved renal performance and minimized pathological alterations in the glomerulus of STZ-Nrf2+\/+ mice. Nrf2 activation reduced oxidative damage and suppressed the expression of TGF-\u03b21, extracellular matrix proteins and p21 both in vivo and in HRMCs. In addition, Nrf2 activation reverted p21-mediated growth inhibition and hypertrophy of HRMCs under hyperglycemic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>We provide experimental evidence indicating that dietary compounds targeting Nrf2 activation can be used therapeutically to improve metabolic disorder and relieve renal damage induced by diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db11-0807","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T18:12:19Z","timestamp":1319479939000},"page":"3055-3066","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":467,"title":["Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy"],"prefix":"10.2337","volume":"60","author":[{"given":"Hongting","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona"},{"name":"Department of Endocrinology, Xinqiao Hospital, Third Military Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Whitman","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona"},{"name":"Department of Endocrinology, Xinqiao Hospital, Third Military Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg T.","family":"Wondrak","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak K.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Aerospace and Mechanical Engineering, University of Arizona, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna D.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2011,10,17]]},"reference":[{"key":"2022031222525076300_B1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpendmet0894","article-title":"The pathogenesis of diabetic nephropathy","volume":"4","author":"Dronavalli","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2022031222525076300_B2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","article-title":"A glimpse of various pathogenetic mechanisms of diabetic nephropathy","volume":"6","author":"Kanwar","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"2022031222525076300_B3","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.2174\/092986710793348581","article-title":"Oxidative stress in diabetic nephropathy","volume":"17","author":"Kashihara","year":"2010","journal-title":"Curr Med Chem"},{"key":"2022031222525076300_B4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ki.1994.291","article-title":"Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy","volume":"46","author":"Shankland","year":"1994","journal-title":"Kidney Int"},{"key":"2022031222525076300_B5","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031222525076300_B6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diab.45.4.522","article-title":"Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice","volume":"45","author":"Sharma","year":"1996","journal-title":"Diabetes"},{"key":"2022031222525076300_B7","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.ASN.0000093460.24823.5B","article-title":"Mediators of diabetic renal disease: the case for TGF-beta as the major mediator","volume":"15","author":"Ziyadeh","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2022031222525076300_B8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.phrs.2008.09.003","article-title":"Dual roles of Nrf2 in cancer","volume":"58","author":"Lau","year":"2008","journal-title":"Pharmacol Res"},{"key":"2022031222525076300_B9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1196\/annals.1427.036","article-title":"The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration","volume":"1147","author":"Johnson","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"2022031222525076300_B10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1084\/jem.20050538","article-title":"Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice","volume":"202","author":"Rangasamy","year":"2005","journal-title":"J Exp Med"},{"key":"2022031222525076300_B11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/db09-1342","article-title":"The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy","volume":"59","author":"Jiang","year":"2010","journal-title":"Diabetes"},{"key":"2022031222525076300_B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2022031222525076300_B13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/DMDI.2000.17.1-4.3","article-title":"Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins","volume":"17","author":"Kensler","year":"2000","journal-title":"Drug Metabol Drug Interact"},{"key":"2022031222525076300_B14","first-page":"603","article-title":"Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice","volume":"26","author":"Kanematsu","year":"2011","journal-title":"Oncol Rep"},{"key":"2022031222525076300_B15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejphar.2005.11.053","article-title":"Delayed occurrence of H-ras12V-induced hepatocellular carcinoma with long-term treatment with cinnamaldehydes","volume":"530","author":"Moon","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2022031222525076300_B16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainres.2010.04.036","article-title":"Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme","volume":"1343","author":"Ping","year":"2010","journal-title":"Brain Res"},{"key":"2022031222525076300_B17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1073\/pnas.0804333106","article-title":"Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice","volume":"106","author":"Sussan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031222525076300_B18","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3390\/molecules15053338","article-title":"The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells","volume":"15","author":"Wondrak","year":"2010","journal-title":"Molecules"},{"key":"2022031222525076300_B19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2443.2008.01234.x","article-title":"Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice","volume":"13","author":"Yoh","year":"2008","journal-title":"Genes Cells"},{"key":"2022031222525076300_B20"},{"key":"2022031222525076300_B21","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/db06-1003","article-title":"Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease","volume":"57","author":"Xue","year":"2008","journal-title":"Diabetes"},{"key":"2022031222525076300_B22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000324694","article-title":"Attenuation of glomerular injury in diabetic mice with tert-butylhydroquinone through nuclear factor erythroid 2-related factor 2-dependent antioxidant gene activation","volume":"33","author":"Li","year":"2011","journal-title":"Am J Nephrol"},{"key":"2022031222525076300_B23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbadis.2011.03.008","article-title":"Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling","volume":"1812","author":"Palsamy","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2022031222525076300_B24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2008.11.007","article-title":"Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway","volume":"235","author":"Song","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"2022031222525076300_B25","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031222525076300_B26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2009.06.010","article-title":"Nrf2 protects against As(III)-induced damage in mouse liver and bladder","volume":"240","author":"Jiang","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"2022031222525076300_B27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0378-4347(99)00542-3","article-title":"Fast quantification of the urinary marker of oxidative stress 8-hydroxy-2\u2032-deoxyguanosine using solid-phase extraction and high-performance liquid chromatography with triple-stage quadrupole mass detection","volume":"738","author":"Renner","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"2022031222525076300_B28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0891-5849(01)00462-2","article-title":"Measurement of 8-oxo-2\u2032-deoxyguanosine and 8-oxo-2\u2032-deoxyadenosine in DNA and human urine by high performance liquid chromatography-electrospray tandem mass spectrometry","volume":"30","author":"Weimann","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"2022031222525076300_B29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.freeradbiomed.2008.04.023","article-title":"Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress","volume":"45","author":"Wondrak","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"2022031222525076300_B30"},{"key":"2022031222525076300_B31","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/MCB.00248-10","article-title":"A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62","volume":"30","author":"Lau","year":"2010","journal-title":"Mol Cell Biol"},{"key":"2022031222525076300_B32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/jpet.109.162271","article-title":"Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice","volume":"333","author":"Aleksunes","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"2022031222525076300_B33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biochi.2010.10.006","article-title":"Effects of cinnamaldehyde on the glucose transport activity of GLUT1","volume":"93","author":"Plaisier","year":"2011","journal-title":"Biochimie"},{"key":"2022031222525076300_B34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/db10-1164","article-title":"Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"key":"2022031222525076300_B35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nrendo.2010.212","article-title":"Oxidative stress in early diabetic nephropathy: fueling the fire","volume":"7","author":"Singh","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2022031222525076300_B36","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.diabres.2008.09.016","article-title":"Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy","volume":"82","author":"Ziyadeh","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031222525076300_B37","first-page":"901","article-title":"Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease","volume":"24","author":"Lee","year":"2009","journal-title":"Histol Histopathol"},{"key":"2022031222525076300_B38","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/01.ASN.0000031828.58276.02","article-title":"Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy","volume":"13","author":"Abdel-Wahab","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2022031222525076300_B39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000114557.75244.5F","article-title":"Exogenous attenuation of p21(Waf1\/Cip1) decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1","volume":"15","author":"Fan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2022031222525076300_B40","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1681\/ASN.V96986","article-title":"The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy","volume":"9","author":"Kuan","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2022031222525076300_B41","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.ASN.0000013162.29833.45","article-title":"The hypertrophic effect of transforming growth factor-beta is reduced in the absence of cyclin-dependent kinase-inhibitors p21 and p27","volume":"13","author":"Monkawa","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2022031222525076300_B42","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1046\/j.1523-1755.1999.00728.x","article-title":"The cyclin kinase inhibitor p21WAF1\/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy","volume":"56","author":"Al-Douahji","year":"1999","journal-title":"Kidney Int"},{"key":"2022031222525076300_B43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000327599","article-title":"Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD","volume":"33","author":"Pergola","year":"2011","journal-title":"Am J Nephrol"},{"key":"2022031222525076300_B44","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/diabetes.52.8.2110","article-title":"Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine","volume":"52","author":"Babaei-Jadidi","year":"2003","journal-title":"Diabetes"},{"key":"2022031222525076300_B45","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00125-004-1582-5","article-title":"High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats","volume":"47","author":"Babaei-Jadidi","year":"2004","journal-title":"Diabetologia"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/60\/11\/3055\/401065\/3055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/60\/11\/3055\/401065\/3055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T22:53:24Z","timestamp":1713048804000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/60\/11\/3055\/33477\/Therapeutic-Potential-of-Nrf2-Activators-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,17]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,10,17]]},"published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db11-0807","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,17]]}}}